Liver Metastases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2024-08-14
FDA Approved: EOVIST — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for EOVIST (gadoxetate disodium) by Bayer, updating the product labeling. The change involves expans…